Utang jangka cendhak marang modal: Ainos Inc (AIMD)

Ainos, Inc. (AIMD) develops innovative sensors for respiratory diagnostics, monetizing the sale of consumables through patent protection. The firm's environmental strategy focuses on reagent recycling and plastic reduction. The business relies on AI medicine and rapid tests, ensuring sustainable diversification. The current metric is 4.30, and the price trend reflected below demonstrates the dynamics of debt obligations and equity.

Ainos, Inc. development of portable tests to reduce environmental impact requires flexible financing; therefore, changes in the share of short-term liabilities within the capital structure reflect the company's reliance on operational loans. This metric measures the pressure of current costs and inflation on net income, allowing investors to assess the risk of margin compression or, conversely, the efficiency of utilizing short-term resources to accelerate business expansion.